2021
DOI: 10.1259/bjr.20200483
|View full text |Cite
|
Sign up to set email alerts
|

Multiparametric MR evaluation of uterine leiomyosarcoma and STUMP versus leiomyoma in symptomatic women planned for high frequency focussed ultrasound: accuracy of imaging parameters and interobserver agreement for identification of malignancy

Abstract: Objective: To assess accuracy of and interobserver agreement on multiparametric MR findings to distinguish uterine leiomyoma (LM) from uterine leiomyosarcoma (LMS) and soft tissue tumour of unknown malignant potential. Methods: Inclusion criteria: All females over 18 years with least one uterine mass measuring 5 cm or more in at least one of the three standard orthogonal dimensions on MR with histopathological confirmation of LM, LMS, or soft tissue tumour of unknown malignant potential (STUMP) in the 3 months… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0
1

Year Published

2021
2021
2025
2025

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 14 publications
(9 citation statements)
references
References 32 publications
0
8
0
1
Order By: Relevance
“…In particular, AI-based analyses of radiological, histological and molecular features could improve the diagnostic and therapeutic pathway of UBCs. In fact, the availability of diagnostic and prognostic biomarkers is still an unmet clinical need in EC and USa [ 17 , 18 ]. More specifically, integration of multi-omic data through AI systems could bypass the conventional clinical and molecular risk classifications (ESMO risk [ 19 ] and TCGA subclasses [ 3 ]) to allow a more personalized management of EC.…”
Section: Discussionmentioning
confidence: 99%
“…In particular, AI-based analyses of radiological, histological and molecular features could improve the diagnostic and therapeutic pathway of UBCs. In fact, the availability of diagnostic and prognostic biomarkers is still an unmet clinical need in EC and USa [ 17 , 18 ]. More specifically, integration of multi-omic data through AI systems could bypass the conventional clinical and molecular risk classifications (ESMO risk [ 19 ] and TCGA subclasses [ 3 ]) to allow a more personalized management of EC.…”
Section: Discussionmentioning
confidence: 99%
“…While transvaginal ultrasound is the initial imaging test of choice, MR imaging plays a role to assess the extent of disease, exclude other pathologies and weigh possible advantages or disadvantages of UAE versus other treatment options. [36][37][38][39][40][41][42][43] Indications and contraindications UAE is indicated for the treatment of uterine leiomyomata that are causing significant symptoms such as heavy or prolonged menstrual bleeding (hypermenorrhea), pelvic pressure or pain related to identified leiomyomata, including dyspareunia (Table 1). Most females will experience a combination of symptoms.…”
Section: Bjrmentioning
confidence: 99%
“…However, MR imaging can aide in the differentiation of atypical fibroids and uterine sarcomas exist and key features exist, that are more suggestive of a uterine sarcoma. 42,43 Coffin et al seeked to determine the frequency of uterine malignancy in patients evaluated for UAE at a single institution. Uterine malignancy was rare (4/864, 0.46%), and MRI detected the majority, 3 (75%) of 4 before UAE.…”
Section: Bjrmentioning
confidence: 99%
“…In MRI, LBN and benign uterine leiomyomas usually present as well-defined large uterine masses, while LMS usually presents as large uterine masses with ill-defined, irregular margins. 59 The MRI characteristics of different types of USMTs are shown in Figures 6 and 7 . In T1-weighted images, LBN is typically isointense to hypointense to muscle, while benign uterine leiomyomas are isointense to muscle.…”
Section: Different Diagnostic Tools For Lbnmentioning
confidence: 99%